Study of Letrozole in Recurrent Gliomas

NCT03122197 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor

Interventions

DRUG: Letrozole Oral Tablet
DRUG: Temozolomide

Sponsor

University of Cincinnati